OpenURL Connection Search

Select item for more details and to access through your institution.

Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation‐driven medulloblastoma.
Published in:
CNS Neuroscience & Therapeutics, 2022, v. 28, n. 7, p. 1033, doi. 10.1111/cns.13835
By:
- Yao, Yue‐Liang;
- Wang, Yan‐Xia;
- Yang, Fei‐Cheng;
- Wang, Chuan;
- Mao, Min;
- Gai, Qu‐Jing;
- He, Jiang;
- Qin, Yan;
- Yao, Xiao‐Xue;
- Lan, Xi;
- Zhu, Jiang;
- Lu, Hui‐Min;
- Zeng, Hui;
- Yao, Xiao‐Hong;
- Bian, Xiu‐Wu;
- Wang, Yan
Publication type:
Article
Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target.
Published in:
Journal of Pathology, 2021, v. 255, n. 4, p. 374, doi. 10.1002/path.5776
By:
- Zhu, Zheng;
- Wang, Jiao;
- Tan, Juan;
- Yao, Yue‐Liang;
- He, Zhi‐Cheng;
- Xie, Xiao‐Qing;
- Yan, Ze‐Xuan;
- Fu, Wen‐Juan;
- Liu, Qing;
- Wang, Yan‐Xia;
- Luo, Tao;
- Bian, Xiu‐Wu
Publication type:
Article
Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.
Published in:
Journal of Pathology, 2018, v. 245, n. 2, p. 160, doi. 10.1002/path.5062
By:
- Tan, Juan;
- Liu, Mei;
- Zhang, Jun‐Ying;
- Yao, Yue‐Liang;
- Wang, Yan‐Xia;
- Lin, Yong;
- Song, Kang;
- Tan, Jiao;
- Wu, Jin‐Rong;
- Cui, You‐Hong;
- Wang, Yan;
- Bian, Xiu‐Wu
Publication type:
Article
VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
Published in:
Cell Death & Disease, 2018, v. 9, n. 10, p. 1, doi. 10.1038/s41419-018-1015-x
By:
- Zhou, Kai;
- Yao, Yue-Liang;
- He, Zhi-Cheng;
- Chen, Cong;
- Zhang, Xiao-Ning;
- Yang, Kai-Di;
- Liu, Yu-Qi;
- Liu, Qing;
- Fu, Wen-Juan;
- Chen, Ya-Ping;
- Niu, Qin;
- Ma, Qing-Hua;
- Zhou, Rong;
- Yao, Xiao-Hong;
- Zhang, Xia;
- Cui, You-Hong;
- Bian, Xiu-Wu;
- Shi, Yu;
- Ping, Yi-Fang
Publication type:
Article

Found: 4

Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation‐driven medulloblastoma.

Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target.

Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.

VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.